Logo Annals of Transplantation Logo Annals of Transplantation Logo Annals of Transplantation

30 March 2015 : Original article  

The Effect of Graft Type on Mortality in Liver Transplantation for Hepatocellular Carcinoma

Ryan P. CauleyABCDEFG, Kristina PotanosABDEF, Nora FullingtonABDEF, James GrijalvaCDEF, Dionne A. GrahamABCDE, Heung Bae KimACDEF, Khashayar VakiliABCDEFG

DOI: 10.12659/AOT.892613

Ann Transplant 2015; 20:175-185

Abstract

BACKGROUND: Liver transplantation (LT) with living-donor (LD-P) and deceased-donor (DD-P) partial grafts for hepatocellular carcinoma (HCC) may be associated with worse outcomes. Using the United Network for Organ Sharing (UNOS), we aimed to: (1) examine the risk of mortality in LT for HCC, (2) to establish if this risk is affected by partial graft use, and (3) to determine if this effect is mitigated by improved tumor-associated risk stratification.

MATERIAL AND METHODS: All first-time adult LT recipients were analyzed (3/2002-12/2012), including 2,353 LD-P, 727 DD-P, and 47,833 DD whole (DD-W) grafts. Cox proportional hazards models were used to examine the risk of mortality given HCC. Interaction/subset analyses were used to examine the effect of tumor-risk and graft-type on outcome. Presence of an HCC exception and low alpha-fetoprotein (AFP) level (<66 ng/mL) were considered favorable.

RESULTS: Overall, HCC was associated with an increased mortality risk compared to the absence of HCC (HR 1.21 [1.15–1.27]), and the use of partial grafts was noted to further intensify this risk. However, HCC with a favorable risk profile had more comparable outcomes to patients without HCC and this finding was similar across all graft-types (Given LD-P: HR 1.14 [0.76–1.73]; Given DD-P: HR1.05 [0.71–1.56]; Given DD-W: HR1.08 [1.02–1.14]). On subset analysis, all graft types had similar outcomes given either favorable-risk HCC or the absence of HCC.

CONCLUSIONS: There is no significant difference in outcomes between whole and partial grafts given (1) patients with HCC with a favorable risk-profile or (2) patients without HCC.

Keywords: Liver Transplantation, Living Donors, Resource Allocation

0 Comments

SARS-CoV-2/COVID-19

06 December 2022 : Original article  

Changes in Physical Activity Due to Fear of COVID-19 and Its Impact on Depression Among Post-Liver Transpla...

Ann Transplant 2022; 27:e938239

12 April 2022 : Letter/Correspondence  

Pancreas Allograft Thrombosis as a Post-COVID-19 Complication in a Diabetic Patient After Pancreas Transpla...

Ann Transplant 2022; 27:e935863

12 November 2021 : Original article  

Coronavirus Disease 2019 (COVID-19) in Solid Organ Transplant Recipients: A Case-Control Study

Ann Transplant 2021; 26:e933152

In Press

17 Mar 2023 : Original article  

Converting from Tenofovir Disoproxil Fumarate to Tenofovir Alafenamide in Patients with Hepatitis B Followi...

Ann Transplant In Press; DOI: 10.12659/AOT.938731  

17 Mar 2023 : Original article  

Levels of Procollagen Type I C-Terminal Pro-Peptide and Galectin-3, Arterial Stiffness Measured By Pulse Wa...

Ann Transplant In Press; DOI: 10.12659/AOT.938137  

08 Mar 2023 : Original article  

Postoperative Outcomes in 415 Patients Following Liver Transplantation Using Extended Donor Criteria: A Stu...

Ann Transplant In Press; DOI: 10.12659/AOT.939060  

08 Mar 2023 : Original article  

Evaluation and Use of Organs from Donors Poisoned by Organophosphorus Pesticide

Ann Transplant In Press; DOI: 10.12659/AOT.939343  

Most Viewed Current Articles

24 Aug 2021 : Review article  

Normothermic Machine Perfusion (NMP) of the Liver – Current Status and Future Perspectives

DOI :10.12659/AOT.931664

Ann Transplant 2021; 26:e931664

26 Jan 2022 : Review article  

Recurrence of Hepatocellular Carcinoma After Liver Transplantation: Risk Factors and Predictive Models

DOI :10.12659/AOT.934924

Ann Transplant 2022; 27:e934924

29 Dec 2021 : Original article  

Efficacy and Safety of Tacrolimus-Based Maintenance Regimens in De Novo Kidney Transplant Recipients: A Sys...

DOI :10.12659/AOT.933588

Ann Transplant 2021; 26:e933588

15 Mar 2022 : Case report  

Combined Liver, Pancreas-Duodenum, and Kidney Transplantation for Patients with Hepatitis B Cirrhosis, Urem...

DOI :10.12659/AOT.935860

Ann Transplant 2022; 27:e935860

Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

Annals of Transplantation eISSN: 2329-0358
Annals of Transplantation eISSN: 2329-0358